Fourth Dimension Wealth LLC Takes Position in Stryker Co. (NYSE:SYK)

Fourth Dimension Wealth LLC acquired a new stake in shares of Stryker Co. (NYSE:SYK - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 680 shares of the medical technology company's stock, valued at approximately $245,000.

A number of other institutional investors have also made changes to their positions in the stock. Kohmann Bosshard Financial Services LLC bought a new position in Stryker in the 4th quarter worth approximately $25,000. Rakuten Securities Inc. increased its holdings in shares of Stryker by 618.2% during the 4th quarter. Rakuten Securities Inc. now owns 79 shares of the medical technology company's stock worth $28,000 after purchasing an additional 68 shares during the period. Centricity Wealth Management LLC acquired a new position in shares of Stryker during the fourth quarter valued at about $30,000. BankPlus Trust Department bought a new stake in shares of Stryker in the fourth quarter valued at about $33,000. Finally, Activest Wealth Management acquired a new stake in Stryker during the fourth quarter worth about $36,000. 77.09% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research analysts recently commented on the company. Roth Mkm upped their target price on Stryker from $405.00 to $456.00 and gave the company a "buy" rating in a research note on Friday, May 2nd. The Goldman Sachs Group set a $422.00 target price on shares of Stryker in a research report on Tuesday, March 4th. JMP Securities restated a "market perform" rating on shares of Stryker in a research note on Monday, May 5th. Needham & Company LLC reiterated a "buy" rating and issued a $442.00 price objective on shares of Stryker in a research note on Friday, March 21st. Finally, Wall Street Zen cut Stryker from a "buy" rating to a "hold" rating in a report on Thursday, March 6th. Five investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $427.30.

Stryker Trading Down 0.4%

NYSE SYK traded down $1.66 during trading hours on Wednesday, hitting $382.12. 281,223 shares of the company's stock were exchanged, compared to its average volume of 1,343,201. The company has a current ratio of 1.95, a quick ratio of 1.32 and a debt-to-equity ratio of 0.59. Stryker Co. has a 1-year low of $314.93 and a 1-year high of $406.19. The stock has a 50-day simple moving average of $368.24 and a 200 day simple moving average of $376.20. The firm has a market cap of $145.85 billion, a price-to-earnings ratio of 49.21, a PEG ratio of 2.93 and a beta of 0.93.

Stryker (NYSE:SYK - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.84 earnings per share for the quarter, beating the consensus estimate of $2.73 by $0.11. Stryker had a net margin of 13.25% and a return on equity of 23.58%. The business had revenue of $5.87 billion for the quarter, compared to analysts' expectations of $5.68 billion. During the same quarter last year, the firm earned $2.50 EPS. The firm's revenue for the quarter was up 11.9% compared to the same quarter last year. On average, equities analysts forecast that Stryker Co. will post 13.47 EPS for the current fiscal year.

Stryker Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, July 31st. Investors of record on Monday, June 30th will be issued a dividend of $0.84 per share. The ex-dividend date is Monday, June 30th. This represents a $3.36 dividend on an annualized basis and a yield of 0.88%. Stryker's dividend payout ratio (DPR) is 45.41%.

Insider Transactions at Stryker

In other Stryker news, Director Ronda E. Stryker sold 200,000 shares of Stryker stock in a transaction that occurred on Tuesday, May 6th. The stock was sold at an average price of $376.96, for a total value of $75,392,000.00. Following the transaction, the director now directly owns 3,417,326 shares of the company's stock, valued at $1,288,195,208.96. The trade was a 5.53% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 5.20% of the company's stock.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.